A review of nanotechnology-based approaches for breast cancer and triple-negative breast cancer

V Jain, H Kumar, HV Anod, P Chand, NV Gupta… - Journal of Controlled …, 2020 - Elsevier
Breast cancer (BC) is one of the most prevalent cancers in women. Triple-negative breast
cancer (TNBC) in which the three major receptors ie estrogen receptor (ER), progesterone …

Polymeric nanoparticles-siRNA as an emerging nano-polyplexes against ovarian cancer

U Rehman, N Parveen, A Sheikh… - Colloids and Surfaces B …, 2022 - Elsevier
Ovarian cancer (OC) is considered fifth-deadliest cancer globally responsible for high
mortality in women. As the conventional therapeutic and diagnostic approaches are …

Lidocaine promoted ferroptosis by targeting miR-382-5p/SLC7A11 axis in ovarian and breast cancer

D Sun, YC Li, XY Zhang - Frontiers in pharmacology, 2021 - frontiersin.org
Ovarian and breast cancer are prevalent female malignancies with increasing occurrence
incidence and metastasis, significantly affecting the health and life quality of women …

[HTML][HTML] Novel curcumin derivative-decorated ultralong-circulating paclitaxel nanoparticles: a novel delivery system with superior anticancer efficacy and safety

Y Wei, M Zeng, C Pi, H Shen, J Yuan… - International journal …, 2022 - ncbi.nlm.nih.gov
Purpose Paclitaxel (PTX) has been widely utilized for the treatment of breast cancer.
However, drawbacks, such as poor aqueous solubility, rapid blood clearance and severe …

Estrone-conjugated PEGylated liposome Co-loaded paclitaxel and carboplatin improve anti-tumor efficacy in ovarian cancer and reduce acute toxicity of chemo-drugs

H Tang, Y Xie, M Zhu, J Jia, R Liu, Y Shen… - International Journal …, 2022 - Taylor & Francis
Purpose Ovarian cancer is the most lethal gynecologic malignancy. The combination of
paclitaxel (PTX) and carboplatin (CBP) is the first-line remedy for clinical ovarian cancer …

The application of carbon nanomaterials in sensing, imaging, drug delivery and therapy for gynecologic cancers: an overview

C Xiao, C Li, J Hu, L Zhu - Molecules, 2022 - mdpi.com
Gynecologic cancers are one of the main health concerns of women throughout the world,
and the early diagnosis and effective therapy of gynecologic cancers will be particularly …

Administration methods of lipid-based nanoparticle delivery systems for cancer treatment

Y Lu, X Pan, Q Nie, Z Zhou, X Dai, O Liu - Biomaterials Science, 2023 - pubs.rsc.org
As nano medications have developed in the recent four decades, nano-delivery systems
have been applied in treating various diseases and are especially common in cancer …

A review on nanocarrier mediated treatment and management of triple negative breast cancer: a Saudi arabian scenario

I Nahvi, S Belkahla, S Biswas, S Chakraborty - Frontiers in Oncology, 2022 - frontiersin.org
People have continued to be petrified by the devastating effects of cancer for decades and
thus a pursuit for developing anticancer agents have seen an ever-increasing trend in the …

Predicting the effectiveness of chemotherapy using stochastic ODE models of tumor growth

S Sharpe, HM Dobrovolny - Communications in Nonlinear Science and …, 2021 - Elsevier
Ordinary differential equation (ODE) models of cancer growth are often used to predict tumor
growth and form the basis for more complex models used in personalized medicine …

Breast cancer targeted treatment strategies: Promising nanocarrier approaches

SP Malliappan, P Kandasamy… - Anti-Cancer Agents …, 2020 - ingentaconnect.com
Breast cancer is the second most common cancer that causes death among women
worldwide. Incidence of breast cancer is increasing worldwide, and the age at which breast …